Experimental eye shot aims to restore sight in Late-Stage blindness

NCT ID NCT06628947

First seen Sep 30, 2025 · Last updated May 17, 2026 · Updated 28 times

Summary

This study tests an experimental drug called KIO-301, given as an eye injection, for people with late-stage retinitis pigmentosa—a disease that causes vision loss. The trial includes 36 adults who have no light perception or very low vision. Participants will receive up to three injections in each eye over several weeks to see if the drug is safe and can improve vision.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cerulea Clinical Trials

    RECRUITING

    East Melbourne, Victoria, 3002, Australia

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Lions Eye Institute

    RECRUITING

    Nedlands, Western Australia, 6009, Australia

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Queensland Eye Institute

    RECRUITING

    Woolloongabba, Queensland, 4102, Australia

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Royal Adelaide Hospital

    RECRUITING

    Adelaide, South Australia, 5000, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Save Sight Institute

    RECRUITING

    Sydney, New South Wales, 2000, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.